CAPR
Capricor Therapeutics, Inc.$9.34+0.43 (+4.83%)Prev Close$8.90·MCap$492.3M·P/E—·Vol2.10M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
9
$8.09M
◆
Net Activity
Net Seller
$8.09M
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Capricor Therapeutics, Inc. (CAPR) has been exclusively selling, with 0 insider purchases totaling $0.00 and 9 insider sales totaling $8.09M. The most recent insider transaction was by Bergmann Anthony (officer: CHIEF FINANCIAL OFFICER), who sold $732.2K worth of shares on Jun 29, 2026. Capricor Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $492.3M.
CAPR Insider Trading Activity
CAPR Insider Buying Activity
The following table shows recent insider purchases of Capricor Therapeutics, Inc. (CAPR) stock reported via SEC Form 4 filings.
CAPR Insider Selling Activity
The following table shows recent insider sales of Capricor Therapeutics, Inc. (CAPR) stock reported via SEC Form 4 filings.